ADA enzyme activity and percentage of cells containing LASN in patient infusions
Infusion . | Protocol day . | ADA, nM/min/108cells . | LASN+ cells, % . | Total cells infused × 108 . | LASN+ cells infused × 107 . |
---|---|---|---|---|---|
Patient 1 | |||||
1 | 0 | 2.7 | — | 14 | — |
2 | 31 | 3.6 | — | 100 | — |
3 | 77 | 7.9 | — | 120 | — |
4 | 126 | — | — | 6 | — |
5 | 153 | 5.3 | 17.8 | 172 | 306 |
6 | 202 | 11.8 | — | 180 | — |
7 | 262 | 10.5 | 18.2 | 120 | 220 |
8 | 314 | 12.4 | 21.2 | 180 | 380 |
9* | 511 | 8.2 | 53.3 | 129 | 690 |
10* | 601 | 20.8 | 46.8 | 64 | 300 |
11* | 707 | 12.4 | 27.4 | 200 | 548 |
Patient 2 | |||||
1 | 0 | 3.9 | 1.51 | 13 | 1.96 |
2 | 27 | 2.1 | 1.53 | 150 | 23 |
3 | 81 | 4.2 | 2.55 | 153 | 39 |
4 | 127 | 3.5 | 1.59 | 54 | 8.6 |
5* | 186 | 3.9 | 2.75 | 36.4 | 10 |
6* | 242 | 4 | 3 | 24 | 7.25 |
7* | 274 | 4.6 | 3.1 | 32 | 9.9 |
8* | 300 | 2.5 | 2.46 | 80.3 | 19.8 |
9* | 343 | 4.9 | — | 74.5 | — |
10* | 398 | 3.3 | 2.02 | 120 | 24 |
11* | 448 | 2.8 | 0.87 | 200 | 17.4 |
12* | 511 | 4 | 0.96 | 161 | 15.5 |
Infusion . | Protocol day . | ADA, nM/min/108cells . | LASN+ cells, % . | Total cells infused × 108 . | LASN+ cells infused × 107 . |
---|---|---|---|---|---|
Patient 1 | |||||
1 | 0 | 2.7 | — | 14 | — |
2 | 31 | 3.6 | — | 100 | — |
3 | 77 | 7.9 | — | 120 | — |
4 | 126 | — | — | 6 | — |
5 | 153 | 5.3 | 17.8 | 172 | 306 |
6 | 202 | 11.8 | — | 180 | — |
7 | 262 | 10.5 | 18.2 | 120 | 220 |
8 | 314 | 12.4 | 21.2 | 180 | 380 |
9* | 511 | 8.2 | 53.3 | 129 | 690 |
10* | 601 | 20.8 | 46.8 | 64 | 300 |
11* | 707 | 12.4 | 27.4 | 200 | 548 |
Patient 2 | |||||
1 | 0 | 3.9 | 1.51 | 13 | 1.96 |
2 | 27 | 2.1 | 1.53 | 150 | 23 |
3 | 81 | 4.2 | 2.55 | 153 | 39 |
4 | 127 | 3.5 | 1.59 | 54 | 8.6 |
5* | 186 | 3.9 | 2.75 | 36.4 | 10 |
6* | 242 | 4 | 3 | 24 | 7.25 |
7* | 274 | 4.6 | 3.1 | 32 | 9.9 |
8* | 300 | 2.5 | 2.46 | 80.3 | 19.8 |
9* | 343 | 4.9 | — | 74.5 | — |
10* | 398 | 3.3 | 2.02 | 120 | 24 |
11* | 448 | 2.8 | 0.87 | 200 | 17.4 |
12* | 511 | 4 | 0.96 | 161 | 15.5 |
— indicates not available for analysis.
CD8-depleted cultures.